Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Sign Up to like & getrecommendations! Published in 2020 at "Autoimmunity Reviews"
DOI: 10.1016/j.autrev.2020.102568
Abstract: Abstract A hyperinflammatory syndrome (HIS) may cause a life-threatening acute respiratory distress syndrome (ARDS) in patients with COVID-19 pneumonia. A prospective series of 100 consecutive patients admitted to the Spedali Civili University Hospital in Brescia… read more here.
Keywords: covid pneumonia; hyperinflammatory syndrome; brescia italy; acute respiratory ... See more keywords